USDA Delays DEA-Required Marijuana Testing Due to 'Insufficient Capacity'

Dec.13.2022
USDA Delays DEA-Required Marijuana Testing Due to 'Insufficient Capacity'
USDA delays cannabis testing rule due to insufficient DEA-certified labs, worrying about lab capacity for 2023 growing season.

The United States Department of Agriculture (USDA) is delaying the implementation of a rule requiring marijuana to be tested by laboratories certified by the Drug Enforcement Administration (DEA). This is due to concerns over the "inadequate capabilities" of such facilities.


The US Department of Agriculture announced last week in a notice that it is extending the deadline for the enforcement of regulations on marijuana. The notice explains that the DEA laboratory testing requirements will not take effect as planned on January 1st. This controversial regulation is set to take effect on December 31, 2023, at the earliest.


The department stated that they are delaying the implementation of these requirements due to issues with the DEA laboratory registration process, as well as input from state and tribal governments and third-party cannabis testing facilities. Due to these delays, the USDA is concerned that there may not be enough cannabis laboratory testing capacity for the 2023 growing season, which could hinder the growth of the US cannabis market during this critical phase. It is important that laboratory testing of cannabis is in compliance with all other regulatory requirements.


Industry stakeholders in the United States have been criticizing the proposed requirement that only facilities registered with the DEA should conduct THC testing of marijuana. They argue that limited capacity has caused a bottleneck and that testing can be done effectively even without certification from the federal drug administration.


Earlier this year, Representative Chellie Pingree (D-ME) introduced a bill that would make multiple modifications to cannabis regulations, including the elimination of the requirement for DEA-registered labs to conduct testing.


US Agriculture Secretary Tom Vilsack has ultimately approved a broad federal rule that established regulations for the marijuana industry last year, despite concerns raised by advocates over certain provisions. This comes two years after the federal legalization of marijuana crops under the 2018 Agriculture Act.


Meanwhile, the United States Department of Agriculture is conducting an investigation to gather more information on cannabis production and the industry's economy.


At the same time, the agency also took measures to improve the insurance policies of cannabis businesses, making them more flexible in responding to stakeholder feedback.


2FIRSTS will continue to follow and report on this topic. Further updates will be available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
North Carolina hemp provider JLT Imports Inc. has filed suit in California federal court seeking cancellation of the “Lost Mary” vape trademark held by Chinese company Imiracle (HK) Ltd.
Mar.30 by 2FIRSTS.ai
FDA Authorizes Glas Vape but Flavor Hopes Fall Short
FDA Authorizes Glas Vape but Flavor Hopes Fall Short
The FDA has added Glas products to its authorized electronic nicotine delivery systems (ENDS) list, granting Marketing Granted Orders (MGOs) to the Glas G DEVICE and a BLONDE TOBACCO pod. The decision expands the number of FDA-authorized ENDS products to 41, marking the first new authorization since Juul’s approvals in July 2025. However, widely anticipated non-tobacco flavored products were not approved.
Mar.13
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea’s Health Ministry says amendments to the Tobacco Business Act will take effect on April 24, bringing synthetic-nicotine e-liquid vapes under the legal definition of tobacco. The shift extends cigarette-style rules to these products, including mandatory graphic warnings, sharply limited advertising channels, stricter vending-machine placement requirements, and a ban on use in smoke-free areas, with enforcement checks slated from late April.
Feb.03 by 2FIRSTS.ai
UK Smoke-Free Generation Plan Backed by Both Houses of Parliament
UK Smoke-Free Generation Plan Backed by Both Houses of Parliament
Plans to create a smoke-free generation have received backing from both Houses of Parliament in the UK. On Monday, peers approved the Tobacco and Vapes Bill at its third reading, with the measure aiming to prevent anyone currently aged 17 or younger from ever buying cigarettes.
Mar.11 by 2FIRSTS.ai
BAT Japan Announces McLaren Collaboration “glo Hilo Plus” Limited-Edition Set, Priced at About USD 200
BAT Japan Announces McLaren Collaboration “glo Hilo Plus” Limited-Edition Set, Priced at About USD 200
British American Tobacco Japan (BAT Japan) announced a collaboration with McLaren Racing to launch the “glo Hilo Plus・McLaren Racing Inspired Limited-Edition Set.” Sales begin on March 3 via the glo Store Ginza and the official glo online store. Based on the “glo Hilo Plus,” the set includes a limited-edition device and dedicated accessories, priced at JPY 30,000 (about USD 200).
Mar.03 by 2FIRSTS.ai
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11